You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -3,633.1% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -13.2 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 492.1 | n/a |
Price / Book value | 13.4 |
Latest | Forecast | |
---|---|---|
Revenue | n/a | n/a |
PBT | 0.0% | n/a |
EPS | 0.0% | n/a |
DPS | n/a | n/a |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-06-30 | n/a | -1.36 | -0.94p | -21.3 | 0.0 | n/a | n/a | 0.0% |
2020-06-30 | n/a | -1.62 | -1.17p | -14.6 | 0.0 | n/a | n/a | 0.0% |
2021-06-30 | n/a | -1.50 | -0.01p | -6,419.2 | 0.0 | n/a | n/a | 0.0% |
2022-06-30 | 0.07 | -2.73 | -1.61p | -12.6 | 0.0 | n/a | n/a | 0.0% |
SkinBioTherapeutics gets France approval for psoriasis supplement Sharecast News | 15 Sep |
---|---|
SkinBioTherapeutics selects probiotic blends for acne study Sharecast News | 05 Sep |
SkinBioTherapeutics launching psoriasis supplement in Italy Sharecast News | 21 Jun |
health authority approval for AxisBiotix in France | 15-Sep-23 16:46 |
---|---|
Update on acne programme | 05-Sep-23 14:08 |
Holding(s) in Company | 31-Jul-23 21:36 |